Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Profiles
Research Units
Core Facilities
Sponsored Projects
Publications
Search by expertise, name or affiliation
A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF).
Kline, Geoffrey
(PI)
Texas College of Osteopathic Medicine
Internal Medicine & Geriatrics
Overview
Project Details
Status
Finished
Effective start/end date
25/04/17
→
24/04/21
Funding
Boehringer Ingelheim International GmbH:
$19,257.80
View all
View less
Keywords
Biotechnology & Drug Development, Cardiovascular Research